Answers are grounded in this paper and cite their sources.
Objective: To assess demographic, specimen, diagnostic, and Sydney Reporting System features associated with acid-fast bacilli (AFB) positivity in lymph node fine-needle aspirates. Methods: A retrospective cross-sectional analysis of 100 audited lymph node fine-needle aspiration records from District Hospital, Gwalior (January-March 2026) included records with a Sydney Reporting System category and documented AFB result. The primary outcome was AFB smear status. Age was compared using the Mann-Whitney U test; categorical associations were evaluated using Fisher's exact or Fisher-Freeman-Halton exact tests. Effect sizes, 95% confidence intervals (CIs), false-discovery-rate-adjusted q values, and multivariable logistic regression estimates were reported. Results: AFB was positive in 39/100 records (39.0%; 95% CI, 30.0%-48.8%). Purulent aspirates were positive in 22/26 versus 17/74 non-purulent aspirates (odds ratio (OR), 18.44; 95% CI, 5.58-60.93), and inflammatory/infectious cytology in 36/59 versus 3/41 other diagnoses (OR, 19.83; 95% CI, 5.48-71.78). After adjustment for age and sex, purulent aspirate (adjusted OR (aOR), 8.35; 95% CI, 2.30-30.30; p=0.0013) and inflammatory/infectious cytology (aOR, 10.32; 95% CI, 2.64-40.28; p=0.0008) remained significant. Sydney category was associated with AFB status after multiplicity correction (q=0.0306). Conclusion: Purulent aspirate and inflammatory/infectious cytomorphology were independently associated with AFB positivity. These features may support specimen triage for microbiologic and molecular testing but do not establish diagnostic accuracy. Prospective studies with standardized AFB grading, blinding, independent confirmation, and clinical follow-up are required.
No takes yet. Share an insight, caveat, or question.
PAL et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: